188 related articles for article (PubMed ID: 3463439)
1. Apparent mineralocorticoid excess causing hypertension and hypokalemia in children.
New MI; Stoner E; DiMartino-Nardi J
Clin Exp Hypertens A; 1986; 8(4-5):751-72. PubMed ID: 3463439
[TBL] [Abstract][Full Text] [Related]
2. New findings in apparent mineralocorticoid excess.
DiMartino-Nardi J; Stoner E; Martin K; Balfe JW; Jose PA; New MI
Clin Endocrinol (Oxf); 1987 Jul; 27(1):49-62. PubMed ID: 2820623
[TBL] [Abstract][Full Text] [Related]
3. Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
Al-Harbi T; Al-Shaikh A
J Pediatr Endocrinol Metab; 2012; 25(11-12):1083-8. PubMed ID: 23329753
[TBL] [Abstract][Full Text] [Related]
4. Apparent mineralocorticoid excess syndromes.
Shimojo M; Stewart PM
J Endocrinol Invest; 1995; 18(7):518-32. PubMed ID: 9221270
[TBL] [Abstract][Full Text] [Related]
5. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.
Stewart PM; Walker BR; Holder G; O'Halloran D; Shackleton CH
J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609
[TBL] [Abstract][Full Text] [Related]
6. 11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers.
Gourmelen M; Saint-Jacques I; Morineau G; Soliman H; Julien R; Fiet J
Eur J Endocrinol; 1996 Aug; 135(2):238-44. PubMed ID: 8810740
[TBL] [Abstract][Full Text] [Related]
7. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
RodrÃguez JA
Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
[TBL] [Abstract][Full Text] [Related]
8. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart PM; Corrie JE; Shackleton CH; Edwards CR
J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
[TBL] [Abstract][Full Text] [Related]
9. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.
Oberfield SE; Levine LS; Carey RM; Greig F; Ulick S; New MI
J Clin Endocrinol Metab; 1983 Feb; 56(2):332-9. PubMed ID: 6296185
[TBL] [Abstract][Full Text] [Related]
11. Steroid hormones and hypertension: the cortisol-cortisone shuttle.
Stewart PM; Whorwood CB; Walker BR
Steroids; 1993 Dec; 58(12):614-20. PubMed ID: 8116018
[TBL] [Abstract][Full Text] [Related]
12. Apparent mineralocorticoid excess: type I and type II.
Mantero F; Palermo M; Petrelli MD; Tedde R; Stewart PM; Shackleton CH
Steroids; 1996 Apr; 61(4):193-6. PubMed ID: 8732999
[TBL] [Abstract][Full Text] [Related]
13. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
Pediatr Res; 1997 Jan; 41(1):25-9. PubMed ID: 8979285
[TBL] [Abstract][Full Text] [Related]
14. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
[TBL] [Abstract][Full Text] [Related]
15. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
Palermo M; Shackleton CH; Mantero F; Stewart PM
Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
[TBL] [Abstract][Full Text] [Related]
16. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess.
Speiser PW; Riddick LM; Martin K; New MI
Metabolism; 1993 Jul; 42(7):843-5. PubMed ID: 8393954
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess.
Milford DV; Shackleton CH; Stewart PM
Clin Endocrinol (Oxf); 1995 Aug; 43(2):241-6. PubMed ID: 7554322
[TBL] [Abstract][Full Text] [Related]
19. 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
White PC
Am J Med Sci; 2001 Dec; 322(6):308-15. PubMed ID: 11780688
[TBL] [Abstract][Full Text] [Related]
20. The syndrome of apparent mineralocorticoid excess.
Cooper M; Stewart PM
QJM; 1998 Jul; 91(7):453-5. PubMed ID: 9797927
[No Abstract] [Full Text] [Related]
[Next] [New Search]